ARTICLE | Clinical News
Oral Campylobacter vaccine with mucosal adjuvant: ANTX began a Phase I/II trial in 100 volunteers
September 23, 1996 7:00 AM UTC
Antex Biologics (ANTX), Gaithersburg, Md. Product: Oral Campylobacter vaccine with mucosal adjuvant Indication: Prevent gastroenteritis and diarrhea Status: ANTX began a Phase I/II trial in 100 volunt...